Fortress Biotech (NASDAQ:FBIO) Bolsa, Quote.MetaTitle.unusual-options

Fortress Biotech

Fortress Biotech Inc

Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

ABVC BioPharma

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics

aTyr Pharma

BeyondSpring

CAMP4 Therapeutics Corporation - Common Stock

Camp4 Therapeutics

Cibus

Connect Biopharma Holdings Limited - Ordinary Shares

Connect Biopharma Hldgs

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Gain Therapeutics

InflaRx

Immunic

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Lite Strategy

Macrogenics

Metagenomi

MediciNova

PMV Pharma

Quince Therapeutics

Repare Therapeutics

Spruce Biosciences

Sutro Biopharma

Unicycive Therapeutics, Inc. - Common Stock

Unicycive Therapeutics

XBiotech

Fortress Biotech (FBIO) Previsión

Noticias

Beneficios

Opciones

Calificaciones de analistas

Operaciones de insiders

Interés en corto

Informe de acciones

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Comments

Fortress Biotech Opciones Inusuales

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL